A study revealed a respiratory syncytial virus (RSV) vaccine was 78% effective amongst older US veterans in 2023-2024, also reducing hospitalizations and emergency department visits. However, only 24% of adults above 60 received the vaccine. Unvaccinated veterans with weakened immune systems experienced the highest RSV infection rates, highlighting the vaccine’s significance.
Microsoft Unveils Scareware Blocker for Edge Browser
Microsoft has created a scareware blocker to detect and prevent online scams. Integrated into the Edge browser, the blocker uses machine learning and computer vision
